Skip to Main

Search

Results 751 to 760 of 1,045 for ""

UTSW researchers identify new immunotherapy target: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-immunotherapy-target.html

Researchers at UT Southwestern Medical Center have discovered how a hormone interacts with a receptor on the surface of immune cells to shield cancer cells from the body’s natural defenses. The findings, published in Nature Immunology, could lead to new immunotherapy approaches for treating cancer

A match made in medicine: Match Day celebration marks turning point for UTSW medical students

https://www.utsouthwestern.edu/newsroom/articles/year-2019/match-day.html

Faculty, family, and friends gathered on the basketball court and watched as more than 200 graduating UT Southwestern medical students joined thousands more at medical schools across the country to reveal their futures.

Hypnosis through virtual reality aids in medical recovery: Newsroom, UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/virtual-reality.html

Anesthesiologists are exploring the use of hypnosis through virtual reality to lessen postoperative pain and anxiety in children.

UT Southwestern and Children’s Health receive record-setting gift from Moody Foundation : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/may-pediatrics-campus-gift-moody-foundation.html

UT Southwestern Medical Center and Children’s Health℠ today announced a historic nine-figure grant from the Moody Foundation to support the new $5 billion pediatric campus in Dallas, which broke ground in October 2024. The new hospital will help meet the increasing demand for pediatric health care

In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology

https://www.utsouthwestern.edu/newsroom/articles/year-2025/aug-mangelsdorf.html

In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology Published on: August 09, 2025 • By: Newsroom Share Share on Facebook Share on Twitter Share on LinkedIn Email this page Print this page DALLAS – Aug. 9, 2025 – David J. Mangelsdorf, Ph.D., Chair and Professor of Pharmacology at UT Southwestern Medical Center, a visionary scientist who pioneered the once-obscure realm of orphan nuclear receptors (a class of proteins involved in gene

2019 Match Day Specialty List: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/match-day-specialty.html

Grouped by specialty, here are the matches achieved by members of the UT Southwestern Medical School Class of 2019.

Researchers show that mutations in human livers can promote tissue regeneration: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2019/tissue-regeneration.html

Genetic mutations that accumulate in the adult liver that can promote regeneration in the context of chronic liver damage.

One in 5 Americans with diabetes don’t know they have it – here’s how to prevent it: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/diabetes-prevention.html

A healthy diet, regular exercise, and sufficient sleep can help prevent the onset of diabetes, a condition affecting more than 37 million Americans, according to Bethany Agusala, M.D., Assistant Professor of Internal Medicine at UT Southwestern.

UTSW orthopedic surgeon honored for his work on diabetic limb salvage: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/diabetic-limb-salvage.html

Hip and knee replacements, sports injuries, trauma. That’s typically what comes to mind when one thinks of orthopedic surgery, not diabetes.

Study offers insight into management of patients who have interstitial pneumonia with autoimmune features : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/july-interstitial-pneumonia.html

Interstitial pneumonia with autoimmune features (IPAF) is a disease with many possible causes and no standard of care, making it particularly difficult to treat. While immunosuppressant drugs are primarily prescribed, they don’t work for all patients.